Notice of Effectiveness

Xtant Medical Holdings, Inc. Filed 2022-10-20 Acc 9999999995-22-003097

Documents 1

2023-07-13 EFFECT Notice of Effectiveness
2022-10-20 EFFECT Notice of Effectiveness
2022-10-20 424B3 Prospectus
2022-10-20 4 President and CEO sold 131,100 shares at an average $0.65 ($85,828)
2022-10-18 CORRESP Correspondence Between Filers and SEC Staff
2022-10-17 UPLOAD SEC-generated Letter
2021-05-18 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…